// App-Quantinova.ai

AB1304 (2018) : Association between concomitant use of sulfasalazine and decrease of anti-ccp antibody levels in rheumatoid arthritis patients treated with tumour necrosis factor inhibitor or abatacept

Researchers

Presenter

  • H.-H. Chen

Principal Investigators

  • D.-Y. Chen

Medical Centers

  • Department of Medical Research

  • Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • ATP/GTP Binding Protein 1

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • leflunomide

  • Adalimumab

  • Etanercept

  • CHS-0214

  • Abatacept

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved